FDA officials say the assistant is flawed, just as the Trump administration stresses AI adoption in healthcare.

The Food and Drug Administration’s new AI tool — touted by Secretary of Health and Human Services (HHS) Robert F. Kennedy, Jr. as a revolutionary solution for shortening drug approvals — is initially causing more hallucinations than solutions.

Known as Elsa, the AI chatbot was introduced to help FDA employees …